<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
YMAB
Y-mAbs Therapeutics
$
()


  • Y-mAbs Therapeutics initiated with a Buy at Brookline on Danyelza potential

    12/5/2024 - 06:21am
  • Y-mAbs Therapeutics initiated with bullish view at Brookline

    12/4/2024 - 19:58pm
  • Y-mAbs Therapeutics initiated with bullish view at Oppenheimer, here's why

    11/18/2024 - 07:40am
  • Morning Movers: Expedia, Airbnb moving in opposite directions after results

    11/8/2024 - 09:00am
  • Y-mAbs Therapeutics backs FY24 revenue view $87M-$95M, consensus $91.67M

    11/8/2024 - 06:39am
  • Y-mAbs Therapeutics reports Q3 EPS (16c), consensus (16c)

    11/8/2024 - 06:38am
  • Y-mAbs, Nobelpharma announce exclusive license, distribution agreement

    11/4/2024 - 07:38am
  • Y-mAbs Therapeutics announces new data on naxitamab, GD2-SADA

    9/6/2024 - 07:33am
  • Cisco, Nike upgrades among today's top calls on Wall Street

    8/16/2024 - 09:38am
  • Cantor starts Y-mAbs with Overweight on pivot to radiopharmaceuticals

    8/16/2024 - 06:18am
  • Y-mAbs Therapeutics initiated with bullish view at Cantor Fitzgerald

    8/16/2024 - 06:08am
  • Y-mAbs Therapeutics price target lowered by $1 at Morgan Stanley, here's why

    8/13/2024 - 07:39am
  • Y-mAbs Therapeutics price target lowered by $1 at BMO Capital, here's why

    8/13/2024 - 07:21am
  • Morning Movers: KeyCorp surges following Scotiabank taking stake

    8/12/2024 - 09:17am
  • Y-mAbs Therapeutics sees annual cash burn $15M-$20M

    8/12/2024 - 06:35am
dynamic_feed Breaking News